Related Experiment Videos
Cardiac transplant donor heart allocation based on prospective tissue matching
1Department of Surgery, Medical College of Pennsylvania, Philadelphia.
The Annals of Thoracic Surgery
|October 1, 1994
Summary
Prioritizing donor hearts by human lymphocyte antigen (HLA) matching, not just waiting time, may reduce heart transplant costs and improve patient outcomes by minimizing rejection risks. This approach could enhance efficiency and patient survival.
Area of Science:
- Immunogenetics
- Transplantation immunology
Background:
- Current heart allocation prioritizes acuity and waiting time, leading to high costs and potential manipulation.
- Rising heart transplant costs are linked to prolonged intensive care unit stays and nosocomial infections.
- International studies suggest patient survival correlates with human lymphocyte antigen (HLA) matching.
Purpose of the Study:
- To evaluate the feasibility of a donor heart allocation system based on HLA matching and waiting time.
- To explore the potential of HLA matching to improve heart transplant outcomes and reduce costs.
Main Methods:
- Retrospective analysis of HLA matching in 39 heart transplant patients over 29 months.
- Assessed the association between fortuitous HLA matching and rejection risk.
- Evaluated the potential HLA matching achievable by testing 47 waiting list patients against accessible donors from 1991.
Main Results:
- An inverse association was observed between retrospective HLA matching and rejection risk (p = 0.03).
- Human lymphocyte antigen (HLA) typing can be performed rapidly using donor peripheral blood.
- Potential for local HLA typing before organ procurement was demonstrated.
Conclusions:
- Donor heart allocation based on HLA matching and waiting time is a feasible alternative.
- Implementing HLA matching could mitigate transplant costs and improve patient survival.
- Prospective tissue matching offers potential outcome advantages over current allocation schemes.